Infinity Pharmaceuticals, Inc. (INFI)
|52 Week Range||0.0056-1.3|
|1y Target Est||-|
|DCF Unlevered||INFI DCF ->|
|DCF Levered||INFI LDCF ->|
|Debt / Equity||-1.69%||Neutral|
Upgrades & Downgrades
Latest INFI news
Why Is Infinity Pharmaceuticals (INFI) Stock Up 84% Today?
8 August 2023
Infinity Pharmaceuticals (NASDAQ: INFI ) stock is rocketing higher on Tuesday morning despite a lack of news from the biopharmaceutical company. Investors seeking out news concerning shares of INFI st...
MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending ...
15 June 2023
SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity Pharmaceutic...
Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Lags Revenue Estimates
28 March 2023
Infinity (INFI) delivered earnings and revenue surprises of 8.33% and 95.43%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Infinity Pharmaceuticals (INFI) Report Negative Q4 Earnings? What You Should Know
28 March 2023
Infinity (INFI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CA...
14 March 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Down 44.4% in 4 Weeks, Here's Why Infinity (INFI) Looks Ripe for a Turnaround
17 November 2022
The heavy selling pressure might have exhausted for Infinity (INFI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts i...
Infinity Pharmaceuticals, Inc. (INFI) Q3 2022 Earnings Call Transcript
14 November 2022
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - Chairma...
Infinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference C...
7 November 2022
Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q2 2022 Results - Earnings Call Transcr...
9 August 2022
Start Time: 16:30 January 1, 0000 4:58 PM ET Infinity Pharmaceuticals, Inc. (NASDAQ:INFI ) Q2 2022 Earnings Conference Call August 09, 2022, 16:30 PM ET Company Participants Adelene Perkins - Chair an...
Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference
17 May 2022
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage repro...